PT  - JOURNAL ARTICLE
AU  - Slingluff, Craig L
AU  - Lewis, Karl D
AU  - Andtbacka, Robert
AU  - Hyngstrom, John
AU  - Milhem, Mohammed
AU  - Markovic, Svetomir N
AU  - Bowles, Tawnya
AU  - Hamid, Omid
AU  - Hernandez-Aya, Leonel
AU  - Claveau, Joel
AU  - Jang, Sekwon
AU  - Philips, Prejesh
AU  - Holtan, Shernan G
AU  - Shaheen, Montaser F
AU  - Curti, Brendan
AU  - Schmidt, William
AU  - Butler, Marcus O
AU  - Paramo, Juan
AU  - Lutzky, Jose
AU  - Padmanabhan, Arvinda
AU  - Thomas, Sajeve
AU  - Milton, Daniel
AU  - Pecora, Andrew
AU  - Sato, Takami
AU  - Hsueh, Eddy
AU  - Badarinath, Suprith
AU  - Keech, John
AU  - Kalmadi, Sujith
AU  - Kumar, Pallavi
AU  - Weber, Robert
AU  - Levine, Edward
AU  - Berger, Adam
AU  - Bar, Anna
AU  - Beck, J Thaddeus
AU  - Travers, Jeffrey B
AU  - Mihalcioiu, Catalin
AU  - Gastman, Brian
AU  - Beitsch, Peter
AU  - Rapisuwon, Suthee
AU  - Glaspy, John
AU  - McCarron, Edward C
AU  - Gupta, Vinay
AU  - Behl, Deepti
AU  - Blumenstein, Brent
AU  - Peterkin, Joanna J
TI  - Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence
AID  - 10.1136/jitc-2021-003272
DP  - 2021 Oct 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e003272
VI  - 9
IP  - 10
4099  - http://jitc.bmj.com/content/9/10/e003272.short
4100  - http://jitc.bmj.com/content/9/10/e003272.full
SO  - J Immunother Cancer2021 Oct 01; 9
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.